Lupin Limited – NSE:LUPIN.NS

Lupin Limited stock price today

INR 945.25
-1282.55
-57.57%
Financial Health
0
1
2
3
4
5
6
7
8
9

Lupin Limited stock price monthly change

+23.92%
month

Lupin Limited stock price quarterly change

+23.92%
quarter

Lupin Limited stock price yearly change

+72.97%
year

Lupin Limited key metrics

Market Cap
985.52B
Enterprise value
1.03T
P/E
38.67
EV/Sales
4.93
EV/EBITDA
22.68
Price/Sales
4.82
Price/Book
6.49
PEG ratio
3.56
EPS
42.05
Revenue
196.56B
EBITDA
39.30B
Income
19.14B
Revenue Q/Q
13.04%
Revenue Y/Y
20.81%
Profit margin
12.46%
Oper. margin
11.47%
Gross margin
62.26%
EBIT margin
11.47%
EBITDA margin
20%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Lupin Limited stock price history

Lupin Limited stock forecast

Lupin Limited financial statements

Lupin Limited (NSE:LUPIN.NS): Profit margin
Jun 2023 47.42B 4.52B 9.54%
Sep 2023 49.39B 4.89B 9.91%
Dec 2023 50.79B 6.13B 12.07%
Mar 2024 48.95B 3.59B 7.34%
Lupin Limited (NSE:LUPIN.NS): Analyst Estimates
2026 238.68B 30.07B 12.6%
2027 258.04B 33.73B 13.07%
  • Analysts Price target

  • Financials & Ratios estimates

0.35%
Yield TTM
Lupin Limited (NSE:LUPIN.NS): Payout ratio
Payout ratio 0%
Lupin Limited (NSE:LUPIN.NS): Dividend Yield
2016 0.51%
2017 0.52%
2019 0.65%
2020 1.02%
2022 0.87%
Lupin Limited (NSE:LUPIN.NS): Debt to assets
Jun 2023 0 0
Sep 2023 234436500000 101.36B 43.24%
Dec 2023 0 0
Mar 2024 239971800000 96.23B 40.1%
Lupin Limited (NSE:LUPIN.NS): Cash Flow
Mar 2023 584.3M 0 0
Jun 2023 4.69B 0 0
Sep 2023 4.95B 0 0
Dec 2023 5.14B 0 0

Lupin Limited alternative data

Lupin Limited (NSE:LUPIN.NS): Employee count
Aug 2023 20,933
Sep 2023 20,933
Oct 2023 20,933
Nov 2023 20,933
Dec 2023 20,933
Jan 2024 20,933
Feb 2024 20,933
Mar 2024 20,933
Apr 2024 20,933
May 2024 20,933
Jun 2024 20,933
Jul 2024 20,933

Lupin Limited other data

  • What's the price of Lupin Limited stock today?

    One share of Lupin Limited stock can currently be purchased for approximately $945.25.

  • When is Lupin Limited's next earnings date?

    Unfortunately, Lupin Limited's (LUPIN.NS) next earnings date is currently unknown.

  • Does Lupin Limited pay dividends?

    Yes, Lupin Limited pays dividends and its trailing 12-month yield is 0.36% with 0% payout ratio. The last Lupin Limited stock dividend of $0 was paid on 11 Sep 2025.

  • How much money does Lupin Limited make?

    Lupin Limited has a market capitalization of 985.52B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 21.39% to 196.56B US dollars.

  • What is Lupin Limited's stock symbol?

    Lupin Limited is traded on the NSE under the ticker symbol "LUPIN.NS".

  • What is Lupin Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Lupin Limited?

    Shares of Lupin Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Lupin Limited's key executives?

    Lupin Limited's management team includes the following people:

    • Ms. Vinita D. Gupta Chief Executive Officer & Executive Director(age: 57, pay: $127,870,000)
  • How many employees does Lupin Limited have?

    As Jul 2024, Lupin Limited employs 20,933 workers.

  • When Lupin Limited went public?

    Lupin Limited is publicly traded company for more then 24 years since IPO on 10 Sep 2001.

  • What is Lupin Limited's official website?

    The official website for Lupin Limited is lupin.com.

  • How can i contact Lupin Limited?

    Lupin Limited can be reached via phone at +91 22 6640 2323.

Lupin Limited company profile:

Lupin Limited

lupin.com
Exchange:

NSE

Full time employees:

19,210

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilar and over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. Lupin Limited network consists of 18 labs, 280 LupiMitra collection centers, and 450 pick-up points. It operates in India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Kalpataru Inspire
Mumbai, 400055

:
ISIN: INE326A01037
CUSIP: Y5362X101